| SunSunday | MonMonday | TueTuesday | WedWednesday | ThuThursday | FriFriday | SatSaturday |
|---|---|---|---|---|---|---|
September 18, 2022
|
September 19, 2022
|
September 20, 2022
|
September 21, 2022(3 events)
All day: Redefining Early Stage Investments (RESI) Boston ConferenceAll day: Redefining Early Stage Investments (RESI) Boston Conference All day The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare. 8:00 am: Institute for Biomedical Entrepreneurship (IBE)8:00 am: Institute for Biomedical Entrepreneurship (IBE) – The IBE is a non-profit celebrating 5 years of helping entrepreneurs accelerate the flow of ideas to the marketplace. The IBE program is a 5 day experiential program that includes a mix of classroom work and hands on project work. Advisors work with participants over the 5 day program to develop and refine their pitch and present to an investor panel on the final day. Since its inception, the IBE has helped over 40 companies launch and over 50 corporate projects see success in the marketplace. 11:00 am: UT Austin College of Natural Sciences Technology & Science Career Fair VIRTUAL11:00 am: UT Austin College of Natural Sciences Technology & Science Career Fair VIRTUAL – The fair offers employers a great opportunity to meet diverse undergraduate and graduate students from all majors, promote your open positions, and build your brand with UT Austin students. |
September 22, 2022(3 events)
All day: Redefining Early Stage Investments (RESI) Boston ConferenceAll day: Redefining Early Stage Investments (RESI) Boston Conference All day The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare. 7:30 am: 2022 iC3 Life Science Summit7:30 am: 2022 iC3 Life Science Summit – The BioNTX iC³ Life Science Summit serves as the forum where leaders come together to discuss strategy, exhibit the broad spectrum of North Texas bioscience research, and where the latest innovation, products and services can be seen. Attendees range from the startup community through large multinationals representing industry sectors such as biotech, pharmaceuticals, healthcare companies, academic research institutions, innovators, and leaders. Also attending will be business development executives, vendor partners, investors, and talent seeking new opportunities. 10:00 am: Biostatistics in IVD Clinical Research – Decoding the Biostatistical Black Box10:00 am: Biostatistics in IVD Clinical Research – Decoding the Biostatistical Black Box – During this webinar, NAMSA’s Principal IVD Biostatistician will examine the benefits of including biostatistics early and often in a clinical trial, provide insight on how to prevent unnecessary delays and walk through two real-world case studies. |
September 23, 2022(2 events)
All day: Redefining Early Stage Investments (RESI) Boston ConferenceAll day: Redefining Early Stage Investments (RESI) Boston Conference All day The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare. 7:30 am: 2022 iC3 Life Science Summit7:30 am: 2022 iC3 Life Science Summit – The BioNTX iC³ Life Science Summit serves as the forum where leaders come together to discuss strategy, exhibit the broad spectrum of North Texas bioscience research, and where the latest innovation, products and services can be seen. Attendees range from the startup community through large multinationals representing industry sectors such as biotech, pharmaceuticals, healthcare companies, academic research institutions, innovators, and leaders. Also attending will be business development executives, vendor partners, investors, and talent seeking new opportunities. |
September 24, 2022
|